The Xper Information Management is Philips’ new personalized cardiovascular workflow solution. The product suite presents a variety of new innovations for reporting, image review, scheduling, inventory and intelligent data management. With tools that enhance efficiency on multiple levels, the solution improves and simplifies workflow for all cardiovascular professionals.

Agfa HealthCare's Scheduling for Cardiology solution, a Web-enabled scheduling solution for resources management within cardiovascular departments, has been designed to be configurable to multiple, personal-based workflows. Scheduling for Cardiology’s Web-based architecture provides viewing and management of resource availability from any point of access to the hospital network.

Siemens introduced the AXIOM Sensis XP - a new generation of integrated recording solutions that increases procedural efficiency, allowing for optimal patient care in the cath lab.

ZOLL Medical Corp. has received FDA clearance to market and sell the ZOLL M Series with Real CPR Help technology. The device enables rescuers to instantly see and hear how well they are performing the rate and depth of CPR chest compressions. The M Series is the Company’s best-selling product to date. The approval extends Real CPR Help to ZOLL’s complete defibrillator product line.

Siemens has introduced the completely redesigned Soarian Cardiology 2.0, which has become an integral part of Nebraska Heart Hospital’s strategy to be at the forefront of treating cardiovascular disease by pursuing comprehensive solutions. The CIVS blends cardiac imaging via syngoDynamics and information technology (IT) to optimize clinical performance and help improve patient outcomes.

Ideal for basic 12-lead resting ECG analysis, the MAC 3500 electrocardiograph unit delivers technology to help clinicians improve reliability and accuracy in cardiac assessments, while also helping to increase productivity and efficiency.

St. Jude Medical Inc. says it has received FDA approval of a new cardiac rhythm management device designed to help physicians manage heart failure (HF) patients, including patients who have or may develop atrial fibrillation (AF).

When used in conjunction with the ev3 embolic protection device, ev3’s PROTÉGÉ RX Carotid Stent has been FDA cleared for the treatment of carotid artery disease in patients who are at high-risk for adverse events from carotid artery surgery. The cleatance was supported by the CREATE (Carotid Revascularization with ev3 Inc.